• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Teva Pharmaceutical Industries

Teva Pharmaceutical Industries

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Research
  1. Today's Top Supply Chain and Logistics News From WSJ

    Today's Top Supply Chain and Logistics News From WSJ

  2. Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017 - Research and Markets

    Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017 - Research and Markets

  3. Global Epinephrine Autoinjector Market to Grow at a CAGR of 14.58%, 2017-2021 with ALK-Abell, Impax Laboratories, Lincoln Medical & Mylan Dominating - Research and Markets

    Global Epinephrine Autoinjector Market to Grow at a CAGR of 14.58%, 2017-2021 with ALK-Abell, Impax Laboratories, Lincoln Medical & Mylan Dominating - Research and Markets

  4. ERYTECH Reports Positive Phase 2b Data for eryaspase for the Treatment of Metastatic Pancreatic Cancer

    ERYTECH Reports Positive Phase 2b Data for eryaspase for the Treatment of Metastatic Pancreatic Cancer

  5. Antifungal Drugs: $16.1 Billion Technologies and Global Markets Report 2017-2021 - Research and Markets

    Antifungal Drugs: $16.1 Billion Technologies and Global Markets Report 2017-2021 - Research and Markets

  6. Global Anti-Infective Vaccines Market - Analysis By Disease Type, Region, Country - Opportunities and Forecasts (2016-2021) - Research and Markets

    Global Anti-Infective Vaccines Market - Analysis By Disease Type, Region, Country - Opportunities and Forecasts (2016-2021) - Research and Markets

  7. Ignyta Announces Full Year 2016 Company Highlights and Financial Results

    Ignyta Announces Full Year 2016 Company Highlights and Financial Results

  8. UPDATE: Pharma says high prices fund drug development -- but this study finds otherwise

    UPDATE: Pharma says high prices fund drug development -- but this study finds otherwise

  9. UPDATE: Trump's 'Obamacare Lite' presents opportunities and perils for investors

    UPDATE: Trump's 'Obamacare Lite' presents opportunities and perils for investors

  10. Sosei Subsidiary Heptares and Daiichi Sankyo to Discover and Develop Novel, Small-Molecules for the Treatment of Pain

    Sosei Subsidiary Heptares and Daiichi Sankyo to Discover and Develop Novel, Small-Molecules for the Treatment of Pain

12345

©2017 Morningstar Advisor. All right reserved.